Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
Yahoo FinanceMar 26 16:30 ET
Q4 2023 Biofrontera Inc Earnings Call
Yahoo FinanceMar 19 01:57 ET
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
Yahoo FinanceFeb 23 08:40 ET
Biofrontera Misses Q2 Top and Bottom Line Estimates; Reaffirms FY23 Outlook
Seeking AlphaAug 11, 2023 07:07 ET
Biofrontera Inc. Announces Voting Results From 2022 Annual Meeting of Stockholders
WOBURN, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced the final voting results
GlobeNewswireDec 16, 2022 08:31 ET
Biofrontera Inc. to Participate in Benchmark's 11th Annual Discovery One-on-One Investor Conference
WOBURN, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be
GlobeNewswireNov 30, 2022 14:11 ET
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK'S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022
Woburn, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. ("Biofrontera" or the "Company") (NASDAQ:BFRI), announced today that they will be participating in Renmark Financial Communications Inc.'s live
GlobeNewswireNov 28, 2022 11:06 ET
Biofrontera Reports Q3 Earnings Beat; Updates FY22 Revenue Guidance Range
Seeking AlphaNov 14, 2022 08:56 ET
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
Globe NewswireNov 10, 2022 11:55 ET
Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference
Globe NewswireOct 20, 2022 11:45 ET
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022
WOBURN, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. ("Biofrontera" or the "Company") (NASDAQ: BFRI), announced today that they will be participating in Renmark Financial Communications
GlobeNewswireOct 12, 2022 14:05 ET
Biofrontera Inc.'s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer Awards
Globe NewswireSep 26, 2022 08:35 ET
Biofrontera Inc.'s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for Dermatology
WOBURN, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that PM360, a publication for marketing decision makers in th
GlobeNewswireAug 18, 2022 11:11 ET
Biofrontera GAAP EPS of -$0.05, revenue of $4.5M; reaffirms FY22 guidance
Biofrontera press release (NASDAQ:BFRI): Q2 GAAP EPS of -$0.05. Revenue of $4.5M (-23.7% Y/Y). As of June 30, 2022, Biofrontera Inc. had cash and cash equivalents of $31.9M, compared with $24.5M as of
Seeking AlphaAug 12, 2022 08:44 ET
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH
Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the comme
GlobeNewswireAug 1, 2022 11:06 ET
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today it has entered into agreements with certain of its holders of
GlobeNewswireJul 27, 2022 08:46 ET
Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence
Named Among the 10 Fastest-Growing Life Sciences Companies to Watch in 2022 by CIOCoverage Magazine New Ameluz® Marketing Campaign Receives Gold 2022 Award of Excellence from The Communicator Awards WOBURN, Mass, June 09, 2022 (GLOBE NEW
GlobeNewswireJun 9, 2022 09:46 ET
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera's Ameluz®
WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, views new data on skin cancer prevalence provided by the American Cancer Socie
GlobeNewswireMay 24, 2022 11:31 ET
Biofrontera Inc. Announces Closing of $9.4 Million Private Placement
WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the closing of its previously-announced $9.4 million private p
GlobeNewswireMay 19, 2022 09:52 ET
Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business Update
Conference call begins at 11:00 a.m. Eastern time today WOBURN, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, t
GlobeNewswireMay 13, 2022 07:10 ET
No Data
No Data